Kewaunee Scientific 배당금 및 환매

배당금 기준 확인 0/6

Kewaunee Scientific 현재 배당금을 지급하지 않습니다.

주요 정보

배당 수익률

1.6%

환매 수익률

총 주주 수익률	1.6%
미래 배당 수익률	n/a
배당금 성장	n/a
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	US$0.760
지급 비율	0%

최근 배당금 및 환매 업데이트

업데이트 없음

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 KEQU 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: KEQU 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

Kewaunee Scientific 시장 대비 배당 수익률

KEQU 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (KEQU)	0%
시장 하위 25% (US)	1.4%
시장 상위 25% (US)	4.3%
업계 평균 (Medical Equipment)	1.6%
애널리스트 예측 (KEQU) (최대 3년)	n/a

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 KEQU 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 KEQU 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: KEQU US 시장에서 주목할만한 배당금을 지급하지 않습니다.

주주에 대한 현금 배당금

현금 흐름 범위: KEQU 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

Kewaunee Scientific 배당금 및 환매

배당금 기준 확인 0/6

주요 정보

최근 배당금 및 환매 업데이트

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific Corporation to Report Q1, 2025 Results on Sep 11, 2024

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific Corporation, Annual General Meeting, Aug 28, 2024

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Kewaunee Scientific Corporation to Report Q4, 2024 Results on Jun 26, 2024

Investor sentiment improves as stock rises 18%

Vice President of Human Resources recently sold US$107k worth of stock

Insider recently sold US$93k worth of stock

Insider notifies of intention to sell stock

Third quarter 2024 earnings released: EPS: US$0.87 (vs US$0.26 in 3Q 2023)

Kewaunee Scientific Corporation to Report Q3, 2024 Results on Mar 06, 2024

Investor sentiment improves as stock rises 18%

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

President recently sold US$137k worth of stock

President notifies of intention to sell stock

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.94 (vs US$0.086 loss in 2Q 2023)

Kewaunee Scientific Corporation to Report Q2, 2024 Results on Dec 06, 2023

First quarter 2024 earnings released: EPS: US$0.86 (vs US$0.27 loss in 1Q 2023)

Kewaunee Scientific Corporation, Annual General Meeting, Aug 23, 2023

New minor risk - Shareholder dilution

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

President exercised options and sold US$92k worth of stock

New minor risk - Insider selling

Insider recently bought US$657k worth of stock

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.47 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.086 loss per share (vs US$1.11 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: US$0.27 loss per share (vs US$0.48 loss in 1Q 2022)

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Kewaunee Scientific Corporation, Annual General Meeting, Aug 24, 2022

Full year 2022 earnings released: US$2.20 loss per share (vs US$1.33 loss in FY 2021)

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Insider recently bought US$421k worth of stock

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Kewaunee Scientific Corporation announced delayed 10-Q filing

First quarter 2022 earnings released: US$0.48 loss per share (vs US$0.22 loss in 1Q 2021)

Full year 2021 earnings released: US$1.33 loss per share (vs US$1.70 loss in FY 2020)

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Third quarter 2021 earnings released: EPS US$0.029 (vs US$0.70 loss in 3Q 2020)

Kewaunee Scientific Corporation to Report Q3, 2021 Results on Mar 10, 2021

New 90-day high: US$13.37

New 90-day high: US$12.56

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

New 90-day high: US$9.79

Second quarter 2021 earnings released: US$0.065 loss per share

Kewaunee Scientific reports Q2 results

New 90-day high: US$9.75

Kewaunee Scientific Corporation to Report Q2, 2021 Results on Dec 09, 2020

New 90-day low: US$8.33

New 90-day low: US$8.72

First quarter earnings released

Kewaunee Scientific Corporation to Report Q1, 2021 Results on Sep 08, 2020

New 90-day high - US$10.25

Kewaunee Scientific Corporation(NasdaqGM:KEQU) dropped from Russell Microcap Growth Index

결제의 안정성과 성장

시장 대비 배당 수익률

주주에 대한 수익 배당금

주주에 대한 현금 배당금

강력한 배당금 지급 기업 알아보기